Bronchitol Recommended for Approval by Australian Advisory Committee
13th
Dec 10
Release Date: 13/12/2010 12:00am
Pharmaxis today announced that at its recent meeting, the Australian Advisory Committee on Prescription Medicines (ACPM) has recommended approval of Bronchitol (inhaled dry powder mannitol) for marketing in Australia for the treatment of cystic fibrosis.
Categories: News and Media